Good morning and welcome to JBT Corporation's first quarter 2024 earnings conference call. My name is Marilu, and I will be your conference operator today. As a reminder, today's call is being recorded. At this time, all lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. If you would like to ask a question during this time, simply press star followed by the number one on your telephone keypad. If you would like to withdraw your question, press star again. Thank you. I will now turn the call over to JBT's Vice President of Corporate Development and Investor Relations, Kedric Meredith, to begin today's conference. Kedric, you may begin. Thank you, Marilu. Good morning, everyone, and welcome to our first quarter 2024 conference call. With me on the call is our Chief Executive Officer, Brian Deck, and Chief Financial Officer, Matt Meister. In today's call, we will use forward-looking statements that are subject to the safe harbor language in yesterday's press release and 8-K filing. JBT's periodic SEC filings also contain information regarding risk factors that may have an impact on our results. These documents are available in the Investor Relations section of our website. Also, our discussion today includes references to certain non-GAAP measures. A reconciliation of these measures to the most comparable GAAP measure can be found in the Investor Relations section of our website. Now I'll turn the call over to Brian. Thanks, Kedric, and good morning, everyone. JBT's first quarter, our seasonally lightest period, came in largely as expected. Consistent with previously outlined commentary, we continued to capture margin expansion with a 60 basis point increase in adjusted EBITDA margins compared with the prior year period. As announced in our April 5th press release, we signed a definitive transaction agreement with Marel. The agreement, which was approved by both companies' board of directors, reflects extensive collaboration between the teams. Based on our diligence, it confirms our belief in the industrial logic of the combination and value creation opportunities for customers, shareholders, and other stakeholders. The agreement also represents a significant step forward in anticipation of the submittal of a voluntary takeover offer. With that, I'll turn the call over to Matt, who will walk you through our first quarter performance. I'll speak about the anticipated recovery in the poultry market and provide greater detail about the progress we've made on the proposed merger with Marel. Matt? Thanks, Brian, and good morning. For the first quarter, our revenue was $392 million, an increase of 1% year-over-year. Our gross margin in the quarter of 35.8%, an improvement of 160 basis points, was driven primarily by the cost-saving benefits of restructuring actions and continued progress on our supply chain initiatives. Adjusted EBITDA of $57 million increased 6% year-over-year, and adjusted EBITDA margin increased 60 basis points to 14.6%. As increases in incentive compensation and in labor inflation partially offset the gross profit improvements we realized in the quarter. From an operating perspective, we are pleased with our continued margin expansion. As we have discussed, we believe that JBT's greatest opportunity for margin improvement is from our supply chain initiatives. In the first quarter alone, we realized savings of approximately $5 million in terms of direct, indirect, and logistics spend. Additionally, we have seen a significant and steady improvement in supplier on-time delivery, driven by our actions to consolidate procurement activity with key suppliers. This has had a meaningful and positive effect on JBT's production efficiency, allowing our businesses to further shift their resources to additional supply chain and manufacturing productivity projects. First quarter adjusted EPS was $0.85 versus $0.61 in the prior year. EPS was positively impacted by our operational improvements, which added about $0.07 per share, as well as $9 million of net interest expense improvement, which contributed about $0.22 per share. This was partially offset by a higher effective tax rate for the quarter, which included a discrete item of approximately $0.03 per share. The first quarter is generally our seasonally slowest free cash flow quarter, and our results in the first quarter reflect our preparation for revenue growth through the remainder of the year. While we still have work to do on working capital management, we remain confident in our ability to achieve a free cash flow conversion rate in excess of 100% for the full year. As of the end of the first quarter of 2024, we completed our multi-year restructuring program, recording total charges of $18 million. All-in cumulative annual run rate savings are on track to be $18 million as we exit the second quarter of 2024. Regarding our full year 2024 outlook, we are reiterating our guidance for adjusted EBITDA at $295 million-$310 million and adjusted EPS at $5.05-$5.45, which at the midpoint represent 11% and 28% year-over-year growth, respectively. We continue to expect organic revenue growth of 4%-6%. However, we did adjust the total revenue range to account for current expectations for foreign exchange translation. Additionally, we have updated guidance for GAAP EPS to a range of $4.40-$4.80 for the following items. First, we revised our expectations for M&A costs, which are now estimated to be $30 million-$35 million for the full year, excluding any transaction contingent fees. Additionally, our updated forecast for net interest income of $2 million includes the impact of our new bridge credit facility secured as part of the expected tender offer for Marel. Finally, in the second quarter, we are forecasting a discrete tax benefit of between $8-$9 million related to the successful implementation of internal tax planning actions. With that, let me turn the call back to Brian. Thanks, Matt. Orders booked in the first quarter of 2024 reflected select market softness in North America. Separately, we experienced some order timing issues in our AGV business, but as we have been saying, that market remains quite robust. And while orders from the poultry industry in North America didn't recover in the first quarter, the economics of that market have continued to improve. Corn input price costs have remained stable, while wholesale poultry pricing has increased due to more favorable supply-demand dynamics. For example, the benchmark large bird deboned breast meat is now hovering around $2 per pound versus less than $1 just five months ago. We're optimistic that the improved poultry industry economics will translate to orders during the second quarter. We are very encouraged by the expanding level of quote activity. Specifically, we are seeing demand for midstream and downstream equipment, which we call secondary and further processing. Producers are looking to increase output and efficiency of their value-added processes to capture more margin dollars and address deferred investments. Geographically, while orders softened year-over-year in North America, as discussed, inbound remains solid in Europe, and Middle East posted a record quarter. In terms of end markets, we enjoyed particular strength in fruit juice processing and convenience meals. Let me switch gears and provide updates on the proposed merger with Marel. As I mentioned earlier, the execution of the definitive transaction agreement was a major milestone in combining our two companies. As outlined in the agreement, preserving Marel's heritage and culture is important to advancing the combined business. In having the opportunity to work closer with Marel since the execution of the transaction agreement, I'm as confident as ever on the compelling industrial logic of the transaction, including meaningful value creation opportunities. We expect substantial revenue synergies, such as cross-selling, enhanced service, and an improved overall value proposition, which we continue to analyze and intend to communicate in connection with the offer launch. Regarding the cost synergies, we expect annual run rate benefits of more than $125 million within three years of transaction close and continue to explore for upside as we refine our work. We anticipate approximately 45% of cost synergies will come from cost of goods sold and approximately 55% from operating expenses. In terms of cost of goods sold, we expect to generate meaningful supply chain savings as the combined company consolidates and optimizes procurement, standardizes components through value add, value engineering processes, and expands best cost country sourcing. We also expect to leverage the combined production capacity and gain efficiencies across a broader footprint. As it relates to OPEX, we expect to realize savings from cost overlaps, including IT systems, public company costs, third-party contracts, and certain back office resources. Additionally, we will leverage the combined company's R&D and selling and service resources to have a greater collective impact for the customer. Since the announcement of the transaction agreement, JBT and Marel have made considerable progress on the conditions required to launch the offer. In mid-April, we initiated the review process of the offer document and prospectus with the Financial Supervisory Authority of Iceland, or the FSA. In May, we expect to file the registration on Form S-4 with the SEC, which will contain a preliminary proxy statement and prospectus. Subject to the approval of the required documents by the FSA, we expect to promptly launch the voluntary takeover offer. At that point, we plan to host a joint transaction-specific investor call. We have secured a fully committed bridge financing facility to guarantee funds for the takeover offer as required and will pursue a conventional long-term financing structure in connection with the closing of the transaction. In terms of other workstreams, we have filed antitrust notification documents in the U.S. and started comparable regulatory clearance work in other filing jurisdictions. In early summer, we expect to commence the formal application for the secondary NASDAQ Iceland listing, and pending approval of the final S-4 by the SEC, expect to hold JBT's shareholder vote later in the summer. While the overall transaction timetable remains primarily dependent on the regulatory clearance process, we continue to plan for our year-end close of the transaction. As always, let me extend my sincere thanks to our teams around the globe that deliver exceptional service and solutions to our customers every day. I would also like to extend my appreciation to our partners at Marel as we work together to advance the value-creating combination of our two great businesses. With that, let's take your questions. Operator? Thank you. The floor is now open for questions. If you have dialed in and would like to ask a question, please press star one on your telephone keypad to raise your hand and join the queue. If you would like to withdraw your question, simply press star one again. If you are called upon to ask your question and are listening via loudspeaker on your device, please pick up your handset and ensure that your phone is not on mute when asking your question. Again, press star 1 to join the queue. Your first question comes from the line of Mig Dobre with Robert W. Baird & Co. Please go ahead. Hey, good morning, guys. It's Joe Grabowski on from Mig this morning. Good morning. Hey, good morning. So I wanted to start with your guidance, your organic sales guidance. Based on the 47%, 53% first-half, second-half split, that would seem to imply organic sales of about 1% in the first half and about 8% or 9% in the second half. Correct me if I'm not right on that. But with orders down a little bit each of the last two quarters, I guess what gives you the confidence that you'll see that level of sales lift in the second half? Sure. I'll speak to that. This is Brian. So first and foremost, we have a strong backlog going into the year-end and as we sit here today. So we do have visibility as to already what's in the backlog and the delivery schedule for that. Secondly, I also say that, as I mentioned on our call, we do expect some improvements over the course of the next few quarters with respect to the poultry industry. As you know, that's about 25% of our general market. So we do expect that to improve as we progress through the course of the year here. So everything really played out as expected in Q1. So no need for us to change any gears. Everything is laying out as we expected with the slight modification of the FX translation. Okay. Great. Thanks. And then maybe just drilling in on the North American poultry end market. I think the slide deck in the prepared remarks, you said you expected some orders to start flowing in the second quarter. I guess maybe the level of visibility into those orders, and is there any risk that maybe they're going to kind of slip into the second half of the year and maybe some of that revenue doesn't get recognized till next year? Well, there's certainly always that risk. But as I sit here today, we looked at the last couple of quarters, we were talking about a strong pipeline. Now we're talking about strong quotes, right? So it's really about those quotes converting to orders as we go through the next couple of quarters. Things can always slip from one quarter to the next. Generally speaking, our lead times are three to six months. So you can even go into the third quarter and still have opportunity to meet your numbers. And what's really encouraging is, again, because of the fundamentals of the business, our customers are making money, which is good. They've opened up the conversations. They're accepting quotes. Honestly, we're quoting like crazy right now. So it's really a matter of getting those quotes converted to orders. I don't think we'll be at full run rate in the second quarter, frankly, but we do expect to see the beginning of that activity and then flow into the third quarter from there. Okay. I'll pass it along. Thanks for taking my questions. Thank you. Your next question comes from the line of Walter Liptak with Seaport Global. Hey, thanks. Good morning, guys. Good morning. I wanted to ask about maybe just to follow on to the last one with the orders. Can you tell us anything about how April went with AGV? The timing of those orders, did they come in April, or are those still something that comes in later in the quarter? And then same thing for poultry. Are you starting to see any lift into April? Sure. We typically don't give individual guidance on months within the quarter, but what I will tell you is a couple of things. One, as we went through the first quarter, every subsequent month got better than the prior. So the trend is generally good, and we do have confidence in the second quarter as a whole. On AGV specifically, the shift from, or I'll say the miss, if you will, in Q1 was somewhere between $10 million-$15 million for AGV, actually closer to 15. We certainly expect that in the second quarter, and generally speaking, we expect a strong quarter from AGV here in the second quarter. So again, everything is essentially laying out as expected with the one exception of the AGV slip of that almost $15 million or so. Okay. Great. And then just maybe another follow-on. You mentioned that the second quarter orders would be better but maybe not full. I wonder if that means that it looked like when I looked back at last year, it looked like it's a tough comp for orders. It was a good order period. Could you get to, say, $445 million, which would be flat orders in the second quarter? Is that what we should be thinking about? Well, without giving specific numbers, I do certainly expect a better quarter in the second quarter, without question. The comp versus last year is tough because if you recall, we had those very large pharma orders, so it's a little bit tough. I tend to not focus on any one individual quarter. I just look at the trends, and I look at, do we have the backlog? Do we have the momentum to continue to support our guidance on revenue? And we feel we do. So I feel good about it, and we'll see how things turn out. But certainly, I do expect improvements sequentially. Okay. Thanks. Yeah, I think the data point about quotes is great, and we get that that's starting to pick up for poultry. I wonder if I could ask one last one on aftermarket sales. They shifted down a little bit in the quarter from last year. I wonder if you can talk about that, maybe talk about the aftermarket and is there a growth rate that you could tell us about? Sure. And so it was an interesting quarter, for sure. And I would say somewhat reversion to the mean. So we actually had, if you happen to recall, first quarter last year, we had really high aftermarket. It was like 56% of our revenue mix and relatively lower equipment. This quarter, we actually grew equipment by about 10% on the revenue line and declined about 8% on the aftermarket. But again, last year, if you recall, first quarter had a tremendous amount of aftermarket and specifically refurbishments as customers started sweating the assets more than they otherwise would. So at 52% mix, we're basically back to the mean. And actually, 52 is quite a strong number for us. But I do generally expect the growth rates for the rest of the year. Actually, I expect equipment to slightly outpace aftermarket for the rest of the year, again, as the recovery and delivery of the backlog. But generally speaking, aftermarket remains probably our best kind of resource, if you will, and stability within our financial statements. So I feel super good about it. And if we hover in this 50% range, we're really well set. Okay. Great. Okay. Thank you. I'll get back to you. Thanks. Again, if you would like to ask a question, press star then the number one on your telephone keypad. We have Walter Liptak again on the queue. Okay. He will. Please Please go ahead. Okay. Great. Thanks, guys. So maybe, Matt, one for you. What's the cadence on the cost savings in the second quarter and for the second half? Is it pretty evenly split? How should we think about that? Well, we will hit the run rate of $18 million in savings by the end of Q2. So I would expect there to be a little bit more that filters into Q3. But for the majority of the savings that we expect to achieve from our restructuring program, that would pretty much play out by the end of Q2. Okay. All right. Great. Yeah. And just to give a little bit more color on that, sorry, Walt. Just to give you a little bit more color on it. Generally speaking, if you look at our margins, I would say, given the restructuring, given the supply chain activity, we expect margins to increase sequentially every quarter in 2024, and every quarter will be better than 2023 from a margin perspective. Okay. Great. Okay. Thanks for that color, Brian. And if I could try one on the Marel synergies. Thanks for all the info on the cost-related synergies. Is there, and I realize you're not putting any numbers on the sales synergies, but can you provide any idea of how you will or may provide us with future guidance? Is it going to be as a percentage of revenue growth, or are you going to be able to put a dollar amount on sales synergies as your plans for synergies come to fruition? Yeah. More likely, we would not. We would give you a target dollar amount, but we may convert that to basis points. We'll see. We're working on it pretty intensely as we speak. But just in terms of the synergy potential itself, there's three or four buckets. And I would say certainly the biggest opportunity is really this better value proposition of fuller line solutions to the customer and pull-through of equipment that we can leverage one another's portfolio. Just to give you a couple of examples, right? JBT is really well known for water jet portioning, right? Certainly, we believe we're the leaders in the market. We feel that given Marel's strength on the primary side and into the secondary side, there could certainly be some pull-through that wouldn't otherwise exist, or the customers would have to figure out a solution on their own. So from an engineering perspective, from a value perspective, pulling that fuller line solution makes it really helpful. Similarly, on the kind of opposite, on the FP side, the further processing side, Marel is particularly strong in forming, where we have some exposure in some products, but they're the leaders, right? But we're overall very strong on the FP side, but that's just a hole in our portfolio. So we would expect to be able to pull through that. So those are just a couple of examples on the product side. Also, I would say on the service side and this is what we hear from our customers. They really want to see improved service. You think about the tremendous opportunity of bringing our very large service capabilities, combine it with their large service capabilities throughout the globe, right, in every continent, bringing those two organizations together to help our customers with their uptime, with their efficiency, and just helping overall, making them a better company. We think that's a tremendous opportunity. So those two are the largest. We'll give more color on some of the other buckets as we get into the joint shareholder call here once we do the offer. But we feel very good about opportunities on the commercial side. Okay. Great. Yeah. Sounds good. Thank you for providing some color on those buckets. Thank you. That concludes our Q&A session. I will turn the call over to Mr. Brian Deck for closing remarks. Thank you all for joining us this morning. As always, Kedric and Marlee will be available if you have any follow-up questions. This concludes today's conference call. You may now disconnect.